reserpine has been researched along with griseofulvin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gillespie, E; Levine, RJ; Malawista, SE | 1 |
| Winship, DH | 1 |
| Chiou, WL; Riegelman, S | 1 |
| Aldinger, EE | 1 |
| Day, TW; Mendoza, F | 1 |
3 review(s) available for reserpine and griseofulvin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmaceutical applications of solid dispersion systems.
Topics: Absorption; Bile Acids and Salts; Chemistry, Pharmaceutical; Chloramphenicol; Dosage Forms; Glycols; Griseofulvin; Kinetics; Reserpine; Solubility; Sulfathiazoles; Suspensions; Thermodynamics; Urea; X-Ray Diffraction | 1971 |
Pharmacologic management of Raynaud's phenomenon.
Topics: Blood Platelets; Blood Viscosity; Fibrinogen; Griseofulvin; Humans; Methyldopa; Nifedipine; Parasympatholytics; Phenoxybenzamine; Raynaud Disease; Receptors, Adrenergic; Reserpine | 1984 |
5 other study(ies) available for reserpine and griseofulvin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Histamine release from rat peritoneal mast cells: inhibition by colchicine and potentiation by deuterium oxide.
Topics: Amines; Animals; Colchicine; Cycloparaffins; Deuterium; Female; Griseofulvin; Histamine Release; Mast Cells; Mitosis; p-Methoxy-N-methylphenethylamine; Peritoneal Cavity; Polymyxins; Rats; Reserpine; Vinblastine | 1968 |
Management of esophageal problems in patients with collagen vascular disease.
Topics: Adrenocorticotropic Hormone; Collagen Diseases; Deglutition Disorders; Esophageal Diseases; Esophageal Stenosis; Esophagitis, Peptic; Esophagus; Gastroesophageal Reflux; Glucocorticoids; Griseofulvin; Humans; Manometry; Radiography; Reserpine | 1970 |
Cardiovascular effects of griseofulvin.
Topics: Adrenal Glands; Animals; Atropine; Blood Pressure; Cardiovascular System; Dogs; Female; Griseofulvin; Heart; Heart Rate; Heart Ventricles; Hexamethonium Compounds; Humans; Male; Muscle Contraction; Mycoses; Phentolamine; Propranolol; Rabbits; Rats; Reserpine | 1968 |